Lanean...
Carvedilol in the failing heart
Patients with chronic heart failure due to left ventricular systolic dysfunction of ischemic or nonischemic etiology have shown improvement in morbidity and mortality with carvedilol therapy. In patients with symptomatic (New York Heart Association class II–IV) heart failure, carvedilol improves lef...
Gorde:
| Argitaratua izan da: | Clin Cardiol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley Periodicals, Inc.
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654897/ https://ncbi.nlm.nih.gov/pubmed/11768738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960241202 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|